Plant-Based Investment Corp.

OTC: CWWBF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Toronto, ONReports USD

#1394 of 1,394 Healthcare companies by revenue73rd-percentile growth

EA Score

——

FH —DQ —GM —SS 21

v0.1 · 5/100 weight · pillars only

↑ balance-sheet leverage, return on assets · ↓ 3-yr revenue growth, market scale

Methodology →

Revenue TTM

-$4.4M

Rev growth YoY (TTM)

-218.9%

Net income (FY)

-$6.3M

Employees

—

Market cap

$275

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue-$3.5M-$3.5M2021

Net income-$6.3M-$6.3M2021

Operating income-$7.8M-$7.8M2021

Total assets$19.9M$19.9M2021

Liabilities$1.7M$1.7M2021

Equity$18.2M$18.2M2021

Revenue trend

FY2018 – FY2021 · USD

$2.2M

FY18

$3.9M

FY19

-$2.6M

FY20

-$3.5M

FY21

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Plant-Based Investment Corp. booked -$3.5M in FY2021 revenue, growing 34% year over year — faster than most Healthcare companies we track, at a 177.7% net margin.

Peers · Healthcare

Targeted Medical Pharma, Inc.——InnerScope Hearing Technologies, Inc.——Ormand Industries Inc——Greenwind Holdings Inc.——

Key facts

CEOPaul Jason Crath

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersToronto, ON

ExchangeOTC: CWWBF

Employees—

IPO date2018-03-02

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.